Radulovic LL - Search Results

1

Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor.

Radulovic LL, Cilla DD, Posvar EL, Sedman AJ, Whitfield LR. Radulovic LL, et al. J Clin Pharmacol. 1995 Oct;35(10):990-4. doi: 10.1002/j.1552-4604.1995.tb04015.x. J Clin Pharmacol. 1995. PMID: 8568017 Clinical Trial.

2

Effect of cimetidine administration on the pharmacokinetics of pirmenol.

Stringer KA, Lebsack ME, Cetnarowski-Cropp AB, Goldfarb AL, Radulovic LL, Bockbrader HN, Chang T, Sedman AJ. Stringer KA, et al. Among authors: radulovic ll. J Clin Pharmacol. 1992 Jan;32(1):91-4. doi: 10.1002/j.1552-4604.1992.tb03794.x. J Clin Pharmacol. 1992. PMID: 1740542

3

Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects.

Posvar EL, Radulovic LL, Cilla DD Jr, Whitfield LR, Sedman AJ. Posvar EL, et al. Among authors: radulovic ll. J Clin Pharmacol. 1996 Aug;36(8):728-31. doi: 10.1002/j.1552-4604.1996.tb04242.x. J Clin Pharmacol. 1996. PMID: 8877677 Clinical Trial.

4

Clinical pharmacokinetics of pregabalin in healthy volunteers.

Bockbrader HN, Radulovic LL, Posvar EL, Strand JC, Alvey CW, Busch JA, Randinitis EJ, Corrigan BW, Haig GM, Boyd RA, Wesche DL. Bockbrader HN, et al. Among authors: radulovic ll. J Clin Pharmacol. 2010 Aug;50(8):941-50. doi: 10.1177/0091270009352087. Epub 2010 Feb 10. J Clin Pharmacol. 2010. PMID: 20147618 Clinical Trial.

5

Lack of interaction of gabapentin with carbamazepine or valproate.

Radulovic LL, Wilder BJ, Leppik IE, Bockbrader HN, Chang T, Posvar EL, Sedman AJ, Uthman BM, Erdman GR. Radulovic LL, et al. Epilepsia. 1994 Jan-Feb;35(1):155-61. doi: 10.1111/j.1528-1157.1994.tb02926.x. Epilepsia. 1994. PMID: 8112239

6

Bioequivalence assessment of a pregabalin capsule and oral solution in fasted healthy volunteers: a randomized, crossover study.

Bockbrader HN, Alvey CW, Corrigan BW, Radulovic LL. Bockbrader HN, et al. Among authors: radulovic ll. Int J Clin Pharmacol Ther. 2013 Mar;51(3):244-8. doi: 10.5414/CP201765. Int J Clin Pharmacol Ther. 2013. PMID: 23357837 Clinical Trial.

7

Pharmacokinetics, mass balance, and induction potential of a novel GABA uptake inhibitor, CI-966 HCl, in laboratory animals.

Radulovic LL, Bockbrader HN, Chang T. Radulovic LL, et al. Pharm Res. 1993 Oct;10(10):1442-5. doi: 10.1023/a:1018915123542. Pharm Res. 1993. PMID: 8272405

8

Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.

Radulovic LL, Türck D, von Hodenberg A, Vollmer KO, McNally WP, DeHart PD, Hanson BJ, Bockbrader HN, Chang T. Radulovic LL, et al. Drug Metab Dispos. 1995 Apr;23(4):441-8. Drug Metab Dispos. 1995. PMID: 7600909

9

Preclinical toxicity of a new oral anticancer drug, CI-994 (acetyldinaline), in rats and dogs.

Graziano MJ, Pilcher GD, Walsh KM, Kasali OB, Radulovic L. Graziano MJ, et al. Invest New Drugs. 1997;15(4):295-310. doi: 10.1023/a:1005937502511. Invest New Drugs. 1997. PMID: 9547672

10

Identification of a pyridinium metabolite in human urine following a single oral dose of 1-[2-[bis[4-(trifluoromethyl)phenyl]methoxy]ethyl]- 1,2,5,6-tetrahydro-3-pyridinecarboxylic acid monohydrochloride, a gamma-aminobutyric acid uptake inhibitor.

Radulovic L, Woolf T, Bjorge S, Taylor C, Reily M, Bockbrader H, Chang T. Radulovic L, et al. Chem Res Toxicol. 1993 May-Jun;6(3):341-4. doi: 10.1021/tx00033a014. Chem Res Toxicol. 1993. PMID: 8318656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters